Making conjoint fit for pharma: Shrink your sample size requirements

In the previous paper of this series “Making conjoint fit for pharma”, we discussed why traditional conjoint approaches overburden respondents in pharma market research. In this paper, we explore the impact of sample size on reliability, the challenges of recruiting enough respondents to drown out the noise, and how a fit-for-pharma conjoint platform solves these challenges.

Request the second paper here, or read the full series.

Back to White Papers

Download the document by filling in the form:

By clicking on the “Submit Request” button you are providing consent for us to store your data and contact you. You may withdraw your consent at any time by instructing us at .

View our Privacy Policy for more information.

Please note that Inpharmation literature and case study materials constitute Inpharmation intellectual property and are intended for the pharmaceutical industry. Inpharmation is under no obligation to distribute these materials to non-pharmaceutical industry employees or competitors.

Scroll Top